IDH1 and central nervous system cancer: Work by Mukherjee et al. investigated these mutations in the context of human ALT gliomas and found that IDH1 R132H mutations led to a consistent downregulation of a number of proteins, two of which being the Shelterin component RAP1, and the DNA damage repair protein XRCC1.